Market Cap ₹25 Cr.
Stock P/E 11.8
P/B 0.9
Current Price ₹14.5
Book Value ₹ 16.4
Face Value 10
52W High ₹28.4
Dividend Yield 0%
52W Low ₹ 13.6
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) |
---|
Net Sales |
Other Income |
Total Income |
Total Expenditure |
Operating Profit |
Interest |
Depreciation |
Exceptional Income / Expenses |
Profit Before Tax |
Provision for Tax |
Profit After Tax |
Adjustments |
Profit After Adjustments |
Adjusted Earnings Per Share |
#(Fig in Cr.) | Mar 2024 | TTM |
---|---|---|
Net Sales | 44 | |
Other Income | 0 | |
Total Income | 44 | |
Total Expenditure | 41 | |
Operating Profit | 3 | |
Interest | 0 | |
Depreciation | 0 | |
Exceptional Income / Expenses | 0 | |
Profit Before Tax | 3 | |
Provision for Tax | 1 | |
Profit After Tax | 2 | |
Adjustments | 0 | |
Profit After Adjustments | 2 | |
Adjusted Earnings Per Share | 1.9 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 0% | 0% | 0% | 0% |
Operating Profit CAGR | 0% | 0% | 0% | 0% |
PAT CAGR | 0% | 0% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | NA% | NA% | NA% | NA% |
ROE Average | 13% | 13% | 13% | 13% |
ROCE Average | 17% | 17% | 17% | 17% |
#(Fig in Cr.) | Mar 2024 |
---|---|
Shareholder's Funds | 16 |
Minority's Interest | 0 |
Borrowings | 1 |
Other Non-Current Liabilities | 0 |
Total Current Liabilities | 6 |
Total Liabilities | 22 |
Fixed Assets | 2 |
Other Non-Current Assets | 3 |
Total Current Assets | 17 |
Total Assets | 22 |
#(Fig in Cr.) | Mar 2024 |
---|---|
Opening Cash & Cash Equivalents | 0 |
Cash Flow from Operating Activities | 3 |
Cash Flow from Investing Activities | -3 |
Cash Flow from Financing Activities | -0 |
Net Cash Inflow / Outflow | 0 |
Closing Cash & Cash Equivalent | 0 |
# | Mar 2024 |
---|---|
Earnings Per Share (Rs) | 1.9 |
CEPS(Rs) | 2.29 |
DPS(Rs) | 0 |
Book NAV/Share(Rs) | 14.46 |
Core EBITDA Margin(%) | 7.44 |
EBIT Margin(%) | 6.49 |
Pre Tax Margin(%) | 6.4 |
PAT Margin (%) | 4.76 |
Cash Profit Margin (%) | 5.72 |
ROA(%) | 9.42 |
ROE(%) | 13.15 |
ROCE(%) | 17.31 |
Receivable days | 64.03 |
Inventory Days | 35.47 |
Payable days | 22.4 |
PER(x) | 0 |
Price/Book(x) | 0 |
Dividend Yield(%) | 0 |
EV/Net Sales(x) | 0.25 |
EV/Core EBITDA(x) | 3.41 |
Net Sales Growth(%) | 0 |
EBIT Growth(%) | 0 |
PAT Growth(%) | 0 |
EPS Growth(%) | 0 |
Debt/Equity(x) | 0.04 |
Current Ratio(x) | 3.02 |
Quick Ratio(x) | 2.27 |
Interest Cover(x) | 69.5 |
Total Debt/Mcap(x) | 0 |
# | Mar 2016 | Sep 2016 | Mar 2017 | Sep 2017 | Mar 2018 |
---|---|---|---|---|---|
Promoter | 98.6 | 98.6 | 98.6 | 98.6 | 98.6 |
FII | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 |
Public | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 |
Others | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 |
# | Mar 2016 | Sep 2016 | Mar 2017 | Sep 2017 | Mar 2018 |
---|---|---|---|---|---|
Promoter | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
FII | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 |
Public | 0 | 0 | 0 | 0 | 0 |
Others | 0 | 0 | 0 | 0 | 0 |
Total | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About